Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
3.665
-0.015 (-0.41%)
Mar 20, 2026, 12:15 PM EDT - Market open
Prime Medicine Market Cap
Prime Medicine has a market cap or net worth of $661.72 million as of March 20, 2026. Its market cap has increased by 124.39% in one year.
Market Cap
661.72M
Enterprise Value
601.37M
1-Year Change
124.39%
Ranking
Category
Stock Price
$3.67
Market Cap Chart
Since the IPO on October 20, 2022, Prime Medicine's market cap has decreased from $1.63B to $661.72M, a decrease of -59.34%. That is a compound annual growth rate of -23.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 19, 2026 | 651.65M | 6.08% |
| Dec 31, 2025 | 614.32M | 64.88% |
| Dec 31, 2024 | 372.58M | -54.41% |
| Dec 29, 2023 | 817.15M | -49.22% |
| Dec 30, 2022 | 1.61B | -1.12% |
| Oct 20, 2022 | 1.63B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alto Neuroscience | 714.30M |
| Theravance Biopharma | 705.36M |
| Eikon Therapeutics | 693.16M |
| Jade Biosciences | 688.95M |
| Lexicon Pharmaceuticals | 686.36M |
| Design Therapeutics | 680.86M |
| Annexon | 671.14M |
| AgomAb Therapeutics NV | 668.18M |